Skip to main content
European Commission logo print header

EuroNanoForum2005 - 'Nanotechnology and the Health of the EU Citizen in 2020'

Objectif

This SSA is for support for a 5-day conference on the theme 'Nanotechnology and the Health of the EU Citizen in 2020' from 5-9 September 2005 in Edinburgh. It is being organized by The Institute of Nanotechnology.
It will build on the success of EuroNanoForum2003, and promote developments in nanotechnology that are leading to innovative solutions for health and healthcare in Europe as part of an integrated and responsible approach. The format will be a combination of thematic workshops, public debate, forums, and conference showing the state-of-the-art.
EuroNanoForum2005 is forming a prestigious element of the UK's 6th Presidency of the EU, which runs from June
to December 2005. It will also be timely in terms of reinforcing the EU policy for research funding for
nanotechnology and converging technologies in the Seventh Framework Programme.
EuroNanoForum2005 will explore several critical issues, such as the ongoing competitiveness of the European
healthcare industries; meeting the demands of an ageing population, the early diagnosis and potential cures, for
example, of cancer, cardiovascular disease and inflammatory diseases. It aims to demonstrate the potential of
nanotechnologies to address these issues, support the creation of high quality jobs, and underpin important EU
objectives such as the Lisbon Agenda.
To achieve its aim, EuroNanoForum2005 will promote exchanges on groundbreaking European research in
nanotechnologies as applied to healthcare, bringing together key industrial players, academia, and policy
makers, in an international context.
Key themes include:
- A review of EU research progress since 2003
- A look to FP7, and the role of convergent technologies in the EU strategy for healthcare
- New developments in tissue engineering; targeted drug delivery; biomaterials; analytical, imaging and sensing
techniques
- How ethical, environmental, social, safety & risk concerns are being addressed
- Nanomedicine for the developing countries

Thème(s)

Data not available

Appel à propositions

FP6-2003-ADHOCSUBV
Voir d’autres projets de cet appel

Régime de financement

SSA - Specific Support Action

Coordinateur

INSTITUTE OF NANOTECHNOLOGY
Contribution de l’UE
Aucune donnée
Adresse
6 The Alpha Centre, Stirling University Innovation Park
STIRLING
Royaume-Uni

Voir sur la carte

Liens
Coût total
Aucune donnée